Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
Jicheng Lv1,2, Hong Zhang1, Muh Geot Wong3, Meg Jardine3, Michelle Hladunewich4, Vivekanand Jha5,6, Helen Monaghan3, Ming‐Hui Zhao1, A. Richard Kitching7, Heather N. Reich8, Vimal K. Derebail8, Richard J. Glassock9, Adeera Levin7, David C. Wheeler10, Mark Woodward11,12,13, Laurent Billot3, Tak Mao Chan14, Fei Liu15, David W. Johnson16, Alan Cass17,18, John Feehally19, Jürgen Floege20, Giuseppe Remuzzi21, Yangfeng Wu22, Rajiv Agarwal23, Hai-Yan Wang1, Vlado Perkovic3
1Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China
2Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China2The George Institute for Global Health, University of New South Wales, Sydney, Australia
3The George Institute for Global Health, University of New South Wales, Sydney, Australia
4Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
5The George Institute for Global Health, New Delhi, India5University of Oxford, Oxford, United Kingdom
6University of Oxford, Oxford, United Kingdom
7The University of British Columbia, Vancouver, British Columbia, Canada
8University Health Network, Toronto, Ontario, Canada
9David Geffen School of Medicine, University of California-Los Angeles
10Royal Free and University College Medical School, London, United Kingdom
11Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland
12The George Institute for Global Health, University of New South Wales, Sydney, Australia10The George Institute for Global Health, University of Oxford, Oxford, United Kingdom11Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland
13The George Institute for Global Health, University of Oxford, Oxford, United Kingdom
14University of Hong Kong, Hong Kong, China
15Research Institute of Nephrology, Jinling Hospital, Nanjing, China.
16Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia
17Menzies School of Health Research, Charles Darwin University, Darwin, Australia
18The George Institute for Global Health, University of New South Wales, Sydney, Australia15Menzies School of Health Research, Charles Darwin University, Darwin, Australia
19University of Leicester, Leicester, United Kingdom
20Division of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany
21Mario Negri Institute for Pharmacological Research and Clinical Research Centre for Rare Diseases, Bergamo, Italy
22Peking University Clinical Research Institute, Beijing, China
23Indiana University School of Medicine, Indianapolis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
JAMA - Journal of the American Medical Association
Tập 318 Số 5
432
Thông tin tác giả